期刊文献+

5-氮杂胞苷对宫颈癌细胞FHIT基因去甲基化及抑制增殖作用 被引量:4

Effect of 5-azacitidine on demethylation of FHIT gene and its inhibiting effect on proliferation of cervical cancer cells
原文传递
导出
摘要 目的:探讨5-氮杂胞苷对Hela宫颈癌细胞脆性组氨酸三联基因(Fragile histidine triad gene,FHIT)启动子去甲基化作用及对其增殖的影响。方法:采用低浓度和高浓度5-氮杂胞苷作用Hela宫颈癌细胞,分别采用BSP和RT-PCR检测处理前后FHIT基因启动子甲基化状态和mRNA表达,应用MTT法检测细胞增殖改变。结果:Hela宫颈癌细胞FHIT基因启动子表现高度甲基化状态(CG位点甲基化率为80%~100%),mRNA表达完全受到抑制,细胞呈指数增殖状态;低浓度5-氮杂胞苷作用后的甲基化率显著降低(10%~40%),细胞增殖速度降低;高浓度组FHIT基因启动子甲基化状态被完全逆转,mRNA表达明显高于低浓度组,细胞增殖速度显著低于正常组和低浓度组。结论:5-氮杂胞苷可逆转Hela宫颈癌细胞FHIT基因甲基化状态,使基因恢复表达而抑制细胞增殖,去甲基化和抑制增殖作用随5-氮杂胞苷剂量增加而增加。 Objective:To explore the effect of 5-azacitidine on demethylation of fragile histidine triad(FHIT) gene promoter and its inhibiting effect on proliferation of cervical cancer cells.Methods:Low concentration 5-azacitidine and high concentration 5-azacitidine were used to treat cervical cancer HeLa cells,bisulfate-sequencing PCR(BSP)and RT-PCR were used to detect the methylation statuses and mRNA expressions of FHIT gene promoter before and after treatment,MTT method was used to detect the change of cell proliferation.Results:FHIT gene promoter in cervical cancer HeLa cells showed high methylation status(the rate of methylation in CG situs was 80%-100%),mRNA expression was inhibited completely,the cervical cancer HeLa cells showed exponential proliferation pattern;after treatment with low concentration 5-azacitidine,the rate of methylation decreased significantly(10%-40%),the speed of cell proliferation decreased;after treatment with high concentration 5-azacitidine,the methylation status of FHIT gene promoter were reversed completely,mRNA expression level was significantly higher than that in low concentration 5-azacitidine group,the speed of cell proliferation was significantly lower than those in normal concentration 5-azacitidine group and low concentration 5-azacitidine group.Conclusion:5-azacitidine can reverse the methylation status of FHIT gene promoter in cervical cancer HeLa cells,recover the gene expression,and inhibit cell proliferation,the demethylation and inhibiting effect on proliferation will strengthen with the increase of 5-azacitidine dose.
出处 《中国妇幼保健》 CAS 北大核心 2012年第6期900-902,共3页 Maternal and Child Health Care of China
关键词 FHIT 宫颈癌 启动子 甲基化 细胞增殖 Fragile histidine triad Cervical cancer Promoter Methylation Cell proliferation
  • 相关文献

参考文献10

  • 1Ohta M, Inoue H, Cotticelli MG et al. The FHIT gene, spanning the chromosome 3p14. 2 fragile site and renal carcinoma - associated t (3 ; 8) breakpoint, is abnormal in digestive tract cancers[J]. Cell, 1996, 84 (4): 587.
  • 2Dincer N, Tezel GG, Sungur Aet al. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland [J]. Oral Oncol, 2010, 46 (3) : 195.
  • 3Tikoo K, Ali IY, Gupta J et al. 5 - Azacytidine prevents cisplatin induced nephrotoxicity and potentiates anticancer activity of cisplatin by involving inhibition of metallothionein, pAKT and DNMT1 expression in chemical induced cancer rats [J]. Toxicol Lett,2009,191 ( 2 - 3 ) : 158.
  • 4蒙亚晴,范余娟,杨开选,罗雪慧,徐红.外阴癌和外阴尖锐湿疣FHIT基因杂合性缺失和微卫星不稳定性[J].中国妇幼保健,2010,25(26):3798-3801. 被引量:1
  • 5吴莺,王世宣,马丁.甲基化修饰对人宫颈癌细胞系中FHIT基因的调控[J].肿瘤防治研究,2007,34(8):557-559. 被引量:4
  • 6Raish M, Dhillon VS, Ahmad Aet al. Promoter hypermethylation in tumor suppressing genes p16 and FHIT and their relationship with estrogen receptor and progesterone receptor status in breast cancer patients from northern India [J]. Transl Oncol, 2009, 2 (4) : 264.
  • 7Yin DT, Wang L, Sun Jet al. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma [J]. Ann Clin Lab Sci, 2010, 40 (3): 267.
  • 8廖琪,崔满华,杜绍敏,李秀岩.Fhit蛋白、C-erbB-2、nm23在子宫内膜癌中的表达及意义[J].中国妇幼保健,2010,25(24):3491-3492. 被引量:2
  • 9Neyaz MK, Kumar RS, Hussain Set al. Effect of aberrant promoter methylation of FHIT and RASSF1A genes on susceptibility to cervical cancer in a North Indian population [J].Biomarkers, 2008, 13 (6) : 597.
  • 10黄海玉,刘小乐,陈衡,彭碧玲.PTEN和FHIT在上皮性卵巢肿瘤中的表达及其临床意义[J].中国妇幼保健,2010,25(5):654-656. 被引量:7

二级参考文献30

  • 1范余娟,杨开选,龙凤宜,刘辉,徐红.三联脆组基因在外阴癌和外阴尖锐湿疣中的表达[J].现代预防医学,2006,33(11):2055-2056. 被引量:1
  • 2Steck PA, Pershouse MA, Jasse SA et al. Identification of a candidate tumour suppressor gene, MMACI at chromosome 10q23.3 that is mutated in multple advanced cancer [J].NatGenet, 1997, 15 (4) : 356.
  • 3Ohta M, Inoue H, Cotticelli MG et al. The human FHIT gene, spanning the ehromosome 3P14.2 fragile site and renal cell carcinoma associated transloeation breakpoint, is abnormal in digestive tract cancer [J]. Cell, 1996, 84:587.
  • 4Hao XP, Willis JE, Pretlow TG et al. Loss of fragile histidine triad expression in coloretal carcinomas and premalignant lesions [J]. Cancer Res, 2000, 60 (1): 18.
  • 5Downes CP, Perera N, Ross Set al. Substrate specificity and acute regulation of the tumour suppressor phosphatase, PTEN[J].Biochem SocSymp, 2007, 7d (1): 69.
  • 6Kurose R, Zhou XP, Araki T et al. Frequent loss of PTEN expression in linked to elevated phosphorylated Alt levels, but not associated with p27 and cyelin D1 expression, in primary epithelial ovarian carcinomas [J]. Am J Pathol, 2001 , 158:2097.
  • 7Schondorf T, Ebert MP. Hypermethylation of the PTEN gene in ovarian cancer lins[J]. Cancer Let, 2004, 207 (2) : 215.
  • 8Chang KW, Kao SY, Tzeng RJ et al. Multiple molecular alterations of FHIT in beta- associated oral carcinoma [ J] . Pathol, 2002, 196 (3) : 300.
  • 9Zochbauer - Muller S, Fong KM, Maitra A el al. 5CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer [J]. Cancer Res, 2001, 61 (9) : 3581.
  • 10Pakarsky Y, Zanesi N, Palamarchnk A, et al. Fhit from gene discovery to cancer treatment and prevention [J] . The Cancer Oncology, 2006, 3 (12): 748.

共引文献10

同被引文献73

  • 1张文淼,帅茨霞,郑飞云,黄引平,王群姬,朱华,何秋香.脆性组氨酸三联体基因在宫颈癌前病变和宫颈癌中的表达及其与p53和HPV16/18的关系[J].中华肿瘤杂志,2006,28(6):452-455. 被引量:26
  • 2吴莺,王世宣,马丁.甲基化修饰对人宫颈癌细胞系中FHIT基因的调控[J].肿瘤防治研究,2007,34(8):557-559. 被引量:4
  • 3章文华主编.子宫颈病变的诊断要点[M].北京:人民卫生出版社,2006:100-107.
  • 4Palumbo E, Tosoni E, Matricardi L,et al. Genetic instability of the tumor suppressor gene FHIT in normal human cells[J]. Genes Chromosomes Cancer, 2013, 52(9):832-844.
  • 5Rabelo RA, Antunes LM, Etchebehere RM, et al. Loss of heterozygosity in the fragile histidine triad (FHIT) locus and expression analysis of FHIT protein in patients with breast disorders[J]. Clin Exp Obstet Gynecol, 2015,40(1):89-94.
  • 6Sinha R, Hussain S, Mehrotra R, et al. Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population [J]. PLoS One,2013,8(4):601-642.
  • 7Saldivar JC, Bene J, Hosseini SA, et al. Characterization of the role of Fhit in suppression of DNA damage[J]. Adv Biol Regul,2013,53(1):77- 85.
  • 8Romero I, Martinez M, Garrido C, et al. The tumour suppressor Fhit pos- itively regulates MHC class I expression on cancer cells[J].J Pathol, 2012,227(3):367-379.
  • 9Jeong Y J, Jeong HY, Lee SM,et al. Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients[J]. Oncol Rep,2013,30(5):2270-2278.
  • 10Diaz RJ, Guduk M, Romagnuolo R,et al. High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesis[J]. Neoplasia,2012,14(9):788-798.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部